Red Door Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2
Closed 204
2021
Q2
$0 Buy
+2
New +$606 ﹤0.01% 623
2020
Q4
Sell
-2,807
Closed -$793K 109
2020
Q3
$793K Buy
2,807
+22
+0.8% +$6.14K 0.58% 50
2020
Q2
$745K Buy
2,785
+284
+11% +$85.4K 0.55% 48
2020
Q1
$791K Buy
2,501
+590
+31% +$179K 0.75% 39
2019
Q4
$570K Buy
+1,911
New +$530K 0.51% 54

Other funds holding BIIB

Red Door Wealth Management's BIIB Position: Q3 2021 in Review

Red Door Wealth Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 2 shares.

Red Door Wealth Management first reported a position in BIIB in Q4 2019 and held it in 5 quarters. The position peaked at $793K in Q3 2020. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Red Door Wealth Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Red Door Wealth Management sold 2 Biogen shares in Q3 2021.
  • Red Door Wealth Management first reported a position in Biogen in Q4 2019 and held it in 5 quarters.
  • Red Door Wealth Management's Biogen position peaked at $793K in Q3 2020.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Red Door Wealth Management's 13F filing for Q3 2021, filed 14 Oct 2021.